The ORS Innovation Committee serves as a hub for orthopaedic clinical translation and the commercialization process of early-stage ideas to provide a home for innovation within the field of orthopaedics.
ORS Industry Alliance Committee
Saturday, February 3
1:00 pm – 2:00 pm
A successful brainstorm is too often inhibited by our preconceived notions of what the solution should already be or what constraints exist for each new idea. This workshop will explore the fundamental principles of brainstorming and discuss how to create an environment that fosters creativity and collaboration. The purpose of this workshop is to introduce the key components of a successful brainstorm and then have participants conduct an interactive exercise to practice those key components. The topics will include learning to separate divergent and convergent thinking, striving for quantity over quality, deferring judgment, and the benefit of “wild” ideas. The goal is to gain a deeper understanding of the creative process and be able to apply the tools learned to future brainstorming sessions.
ORS Industry Alliance Committee
Sunday, February 4
1:00 pm – 2:00 pm
The education and training of engineers, researchers, and scientists focus on technical capabilities as the focal point. This curriculum typically continues as one enters an academic or industry career, as gaining certified qualifications and expertise may be valuable for a given technical skill set. However, this may often leave an individual feeling unprepared when met with challenges outside the technical realm. Navigating a career is challenging, but even more so when there are soft skill gaps. The purpose of this workshop is to discuss what these soft skills are and how one can leverage them. Topics to be discussed will include:(1) How to receive and give better feedback, (2) Understanding that communication is more than speaking, and (3) Negotiation and Advocacy. This session will target early-career through established researchers.
(In collaboration with the ORS Innovation Committee, ORS Spine Section, ORS Industry Alliance Committee, and Guest Clinical Society – NASS)
Sunday, February 4
1:00 pm – 2:30 pm
Organizers:
Neharika Bhadouria, MS, Dino Samartzis, DSc, Gabriela Graziani, MEng, PhD
Spinal diseases present considerable therapeutic hurdles and despite breakthroughs in surgical procedures, implants, and imaging modalities, a large group of patients continue to suffer from chronic pain and impairment following existing treatment. There is an increasing demand for regenerative, non-invasive, or minimally invasive techniques for treating spine problems. There is also a strong need for computational modeling and artificial intelligence-driven pain and degeneration management. In addition, many important topics, such as managing pain, gender-based pathology, and therapy response based on precision remain largely unsolved. This symposium will help in identifying unsolved clinical spine-related problems that require cross-disciplinary expertise and creative collaborations. After the presentations by distinguished speakers from both industry and academia, a brief panel discussion will take place. During the discussion, attendees will also have the opportunity to ask questions to the speakers.
Speakers:
Spine biologics –changing the landscape of new and old spine treatments
Zorica Buser, MD, Gerling Institute
Transforming scientific discoveries into entrepreneurial ventures: The journey ‘from bench to bedside’
Mark Erwin, MD, University of Toronto
Rebuilding life brick by brick: Journey of patients suffering from chronic back pain
Rowley G. Hazard, MD, Dartmouth College
Revolutionizing the spine treatment: Say goodbye to back pain
Ben Goss, MD, Mainstay Medical
Orthopedics on the cutting edge: Exploring the potential of Artificial Intelligence – game-changer or risky move?
Dino Samartzis, DSc, Rush University
ORS Industry Alliance Committee and ORS Innovation Committee
Sunday, February 4
2:45 pm – 4:15 pm
Organizers:
Ata Kiapour and Aric Kaiser
The purpose of this session is to discuss regulatory needs, pathways and challenges associated with software products and AI/ML algorithms developed to assist with diagnosis and treatment planning of a range of musculoskeletal disorders.
Speakers:
Regulatory Approaches for AI-enable Medical Devices; Update from the Center for Digital Health Excellence
Matthew Diamond, FDA
FDA Regulatory Framework for AI/ML Software as Medical Devices in Orthopedics
Sheldon Davis, FDA
De-risking Your FDA Submission; an Industry Perspective
Windi Hary, Elucid
ORS Innovation Committee
Monday, February 5
1:00 pm – 2:30 pm
The purpose of the ORS Business Innovation Competition (BIC) program is to provide the resources and opportunity for both early-stage companies, as well as clinicians, researchers, students of all levels with a great idea in the field of musculoskeletal research to participate in a program to validate the market potential of their technology and develop a commercialization plan through expert mentorship and feedback to assist in translating their ideas from bench to market.
ORS Industry Alliance Committee
Monday, February 5
2:45 pm – 3:45 pm
This round table session will give participants an opportunity to network with professionals from industry, government, and academia involved in translating technology from benchtop to patients. Each of the speakers will introduce themselves and describe their path to their current role. Each professional will then head networking tables and lead discussions and answer questions on their careers and industry collaborations, as well broad professional development topics. We will have participants change tables every ten minutes so they can talk to a variety of professionals. This session will give participants an opportunity to connect with professionals from large and small institutions as well as their peers, providing insights and connections to help guide career choices. This session will be valuable for both students looking for their first position or experienced professionals interested in making a career change.
